Palvella Therapeutics, Inc. Ratios

Ratios Dec2013 Jun2014 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 0.53%-183.60%-472.55%-388.22%-65.46%-93.01%-55.03%-126.41%-145.58%-165.06%43.66%4,054.42%
EBIT Margin 4.46%-134.17%-466.62%-390.31%-57.74%-105.94%-58.68%-115.68%-164.97%-167.84%-27.72%3,277.91%
EBITDA Margin 4.46%-134.17%-466.62%-394.92%-82.46%-86.05%-52.90%-121.17%-142.00%-132.65%41.85%4,053.72%
Operating Margin 4.46%-134.17%-466.62%-390.31%-57.74%-105.94%-58.68%-115.68%-164.97%-167.84%-27.72%3,277.91%
Net Margin 0.53%-183.59%-479.50%-391.00%-69.82%-91.93%-61.15%-126.97%-145.58%-165.06%41.85%4,054.42%
FCF Margin -25.15%-99.40%-454.52%-256.35%189.14%-9.50%-118.69%-165.82%-27.40%-235.40%-32.41%2,511.63%
Efficiency
Assets Average 3.64M10.93M27.90M34.51M69.47M122.61M141.22M123.05M129.28M124.53M51.52M
Equity Average 0.30M9.01M24.57M28.18M18.37M25.73M45.64M41.19M40.89M39.34M-23.28M
Invested Capital 0.79M0.01M19.28M31.13M25.23M11.52M39.94M51.35M31.03M50.76M27.93M-74.48M
Asset Utilization Ratio 0.490.110.170.360.240.330.240.240.210.83
Leverage & Solvency
Interest Coverage Ratio 1.12-2.71-32.78
Debt to Equity 5.650.050.07
Debt Ratio 0.450.040.06
Equity Ratio 0.080.900.820.920.720.110.280.360.300.330.29-9.87
Times Interest Earned 1.12-2.71-32.78
Valuation
Enterprise Value -3.69M-1.49M-18.47M61.70M31.14M240.60M15.93M94.86M69.49M154.63M18.21M1.67M15.84M
Market Capitalization 91.05M60.50M338.20M144.04M199.01M139.93M272.39M77.38M17.99M15.84M
Return Ratios
Return on Sales 0.01%-1.84%-4.80%-3.91%-0.70%-0.92%-0.55%-1.27%-1.46%-1.65%0.44%40.54%
Return on Capital Employed -0.97%-0.54%-0.87%-0.62%-0.41%-0.24%-0.34%-0.66%-0.49%-0.24%
Return on Invested Capital -0.75%-1.18%
Return on Assets 0.00%-0.90%-0.50%-0.66%-0.25%-0.22%-0.18%-0.30%-0.35%-0.34%0.36%
Return on Equity -0.05%-1.09%-0.57%-0.81%-0.96%-1.04%-0.56%-0.90%-1.12%-1.09%-0.80%